Odanacatib | Interleukin Related interleukin-related.com

Product Name :
Odanacatib

Search keywords :
Odanacatib

drugId :
null

Target Vo:
Bone resorption factor

Target Vo Short Name :
Bone resorption factor

Moa_Name:
Bone resorption factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hepatic Insufficiency

Termination Status :
Phase 3 Clinical

China Termination Status :
Phase 3 Clinical

Highest Status:
Discontinued

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT6 Rabbit mAb Protocol
Phospho-BTK(Y223) Rabbit mAb medchemexpress
RUNX2 Antibody: RUNX2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to RUNX2. It can be used for ICC/IF,IHC-P,WB assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts